Czasopismo Psychiatria Spersonalizowana 2026

Review article

Non-medical use of propofol

Rafał Skowronek

Personalized Psychiatry 2026; 5: e94–e96

DOI: https://doi.org/10.5114/psychs.2026.162456

Abstract View text

Review article

Beyond formal availability – determinants of real-world personalisation of psychiatric and psychotherapeutic care for children and adolescents in Poland

Zuzanna O. Sulich

Personalized Psychiatry 2026; 5: e87–e93

DOI: https://doi.org/10.5114/psychs.2026.161667

Abstract View text

Review article

Digital phenotyping in the assessment of relapse risk in adults with alcohol use disorder – opportunities for monitoring and intervention

Zuzanna O. Sulich

Personalized Psychiatry 2026; 5: e81–e86

DOI: https://doi.org/10.5114/psychs.2026.161478

Abstract View text

Review article

Routine outcome monitoring in adolescents with borderline features in psychiatric practice – a narrative review

Krzysztof Jarosław Niedziela

Personalized Psychiatry 2026; 5: e74–e80

DOI: https://doi.org/10.5114/psychs.2026.161438

Abstract View text

Case report

Application of the MMPI-2 test in the diagnosis of autism spectrum disorders – a case study of a patient with high-functioning autism

Kaja K. Wojciechowska, Andrzej Janiak

Personalized Psychiatry 2026; 5: e66–e73

DOI: https://doi.org/10.5114/psychs.2026.161310

Abstract View text

Review article

Therapeutic ornithology in rumination- and self-referential-dominant depression in the digital age – a clinical hypothesis of the mechanism of action

Sławomir Murawiec, Piotr Tryjanowski

Personalized Psychiatry 2026; 5: e55–e65

DOI: https://doi.org/10.5114/psychs.2026.160392

Abstract View text

Review article

When the same words mean different things: adapting psychiatric communication to ASD, ADHD and psychotic processing styles

Sławomir Murawiec, Marta T. Makara-Studzińska, Konrad Jurczakowski

Personalized Psychiatry 2026; 5: e46–e54

DOI: https://doi.org/10.5114/psychs.2026.160006

Abstract View text

Review article

Bupropion in the treatment of problematic use of and dependence on stimulants and cannabis – neurobiological rationale and clinical evidence

Gniewko Więckiewicz

Personalized Psychiatry 2026; 5: e39–e45

DOI: https://doi.org/10.5114/psychs.2026.159527

Abstract View text

Review article

The loneliness of the psychotherapist – an indivisible experience?

Władysław Sterna

Personalized Psychiatry 2026; 5: e30–e38

DOI: https://doi.org/10.5114/psychs.2026.159267

Abstract View text

Review article

Erotomania (de Clérambault’s syndrome) – a review of current knowledge

Ryszard Kujawski

Personalized Psychiatry 2026; 5: e19–e29

DOI: https://doi.org/10.5114/psychs.2026.159110

Abstract View text

Original article

Does monotropism bridge ADHD and ASD? A latent profile analysis in adults

Anna Papińska

Personalized Psychiatry 2026; 5: e8–e18

DOI: https://doi.org/10.5114/psychs.2026.159107

Abstract View text

Review article

Categorical diagnosis vs. dimensional approach in psychiatry: implications for pharmacotherapy

Sławomir Murawiec

Personalized Psychiatry 2026; 5: e1–e7

DOI: https://doi.org/10.5114/psychs.2026.159083

Abstract View text

Non-medical use of propofol

Beyond formal availability – determinants of real-world personalisation of psychiatric and psychotherapeutic care for children and adolescents in Poland

Digital phenotyping in the assessment of relapse risk in adults with alcohol use disorder – opportunities for monitoring and intervention

Routine outcome monitoring in adolescents with borderline features in psychiatric practice – a narrative review

Application of the MMPI-2 test in the diagnosis of autism spectrum disorders – a case study of a patient with high-functioning autism

Therapeutic ornithology in rumination- and self-referential-dominant depression in the digital age – a clinical hypothesis of the mechanism of action

When the same words mean different things: adapting psychiatric communication to ASD, ADHD and psychotic processing styles

Bupropion in the treatment of problematic use of and dependence on stimulants and cannabis – neurobiological rationale and clinical evidence

The loneliness of the psychotherapist – an indivisible experience?

Erotomania (de Clérambault’s syndrome) – a review of current knowledge

Does monotropism bridge ADHD and ASD? A latent profile analysis in adults

Categorical diagnosis vs. dimensional approach in psychiatry: implications for pharmacotherapy

Integrated with

Editorial Policies